Literature DB >> 7717400

Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II.

C F Boerkoel1, R Exelbert, C Nicastri, R C Nichols, F W Miller, P H Plotz, N Raben.   

Abstract

An autosomal recessive deficiency of acid alpha-glucosidase (GAA), type II glycogenosis, is genetically and clinically heterogeneous. The discovery of an enzyme-inactivating genomic deletion of exon 18 in three unrelated genetic compound patients--two infants and an adult--provided a rare opportunity to analyze the effect of the second mutation in patients who displayed dramatically different phenotypes. A deletion of Lys-903 in one patient and a substitution of Arg for Leu-299 in another resulted in the fatal infantile form. In the adult, a T-to-G base change at position -13 of intron 1 resulted in alternatively spliced transcripts with deletion of exon 2, the location of the start codon. The low level of active enzyme (12% of normal) generated from the leakage of normally spliced mRNA sustained the patient to adult life.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7717400      PMCID: PMC1801206     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  52 in total

1.  Rodent and human acid -glucosidase. Purification, properties and inhibition by antibodies. Investigation in type II glycogenosis.

Authors:  T de Barsy; P Jacquemin; P Devos; H G Hers
Journal:  Eur J Biochem       Date:  1972-11-21

2.  Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies.

Authors:  A G Engel
Journal:  Brain       Date:  1970       Impact factor: 13.501

3.  Autophagic glycogenosis of late onset with mitochondrial abnormalities: light and electron microscopic observations.

Authors:  A G Engel; A J Dale
Journal:  Mayo Clin Proc       Date:  1968-04       Impact factor: 7.616

4.  Studies of lysosomal alpha-glucosidase. II. Kinetics of action of the rat liver enzyme.

Authors:  P L Jeffrey; D H Brown; B I Brown
Journal:  Biochemistry       Date:  1970-03-17       Impact factor: 3.162

5.  Acid maltase deficiency: comparison of infantile, childhood, and adult types.

Authors:  A G Engel; M E Seybold; E H Lambert; M R Gomez
Journal:  Neurology       Date:  1970-04       Impact factor: 9.910

6.  Simultaneous absence of alpha-1,4-glucosidase and alpha-1,6-glucosidase activities (pH 4) in tissues of children with type II glycogen storage disease.

Authors:  B I Brown; D H Brown; P L Jeffrey
Journal:  Biochemistry       Date:  1970-03-17       Impact factor: 3.162

7.  Adult myopathy from glycogen storage disease due to acid maltase deficiency.

Authors:  P Hudgson; D Gardner-Medwin; M Worsfold; R J Pennington; J N Walton
Journal:  Brain       Date:  1968-09       Impact factor: 13.501

8.  [Muscular glycogenosis caused by alpha-1,4-glucosidase deficiency simulating progressive muscular dystrophy. (Clinical and enzyme study. Optic and electron microscopy)].

Authors:  V Courtecuissf; P Royer; R Habib; C Monnier; J Demos
Journal:  Arch Fr Pediatr       Date:  1965-12

9.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

10.  alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease).

Authors:  H G HERS
Journal:  Biochem J       Date:  1963-01       Impact factor: 3.857

View more
  33 in total

1.  Dichotomous splicing signals in exon flanks.

Authors:  Xiang H-F Zhang; Christina S Leslie; Lawrence A Chasin
Journal:  Genome Res       Date:  2005-06       Impact factor: 9.043

2.  Seven cases of Pompe disease from Greece.

Authors:  M Kroos; P Manta; I Mavridou; F Muntoni; D Halley; R Van der Helm; D Zaifeiriou; A Van der Ploeg; A Reuser; H Michelakakis
Journal:  J Inherit Metab Dis       Date:  2006-08       Impact factor: 4.982

3.  Molecular diagnosis of German patients with late-onset glycogen storage disease type II.

Authors:  P R Joshi; D Gläser; S Schmidt; M Vorgerd; M Winterholler; K Eger; S Zierz; M Deschauer
Journal:  J Inherit Metab Dis       Date:  2008-07-10       Impact factor: 4.982

Review 4.  Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases?

Authors:  I Maire
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

5.  Identification and Functional Characterization of GAA Mutations in Colombian Patients Affected by Pompe Disease.

Authors:  Mónica Yasmín Niño; Heidi Eliana Mateus; Dora Janeth Fonseca; Marian A Kroos; Sandra Yaneth Ospina; Juan Fernando Mejía; Jesús Alfredo Uribe; Arnold J J Reuser; Paul Laissue
Journal:  JIMD Rep       Date:  2012-04-19

Review 6.  Molecular genetics of Pompe disease: a comprehensive overview.

Authors:  Paolo Peruzzo; Eleonora Pavan; Andrea Dardis
Journal:  Ann Transl Med       Date:  2019-07

Review 7.  Pompe Disease: From Basic Science to Therapy.

Authors:  Lara Kohler; Rosa Puertollano; Nina Raben
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

8.  Genetic screening in Iranian patients with retinoblastoma.

Authors:  K Shahraki; A Ahani; P Sharma; M Faranoush; G Bahoush; I Torktaz; W A Gahl; M Naseripour; B Behnam
Journal:  Eye (Lond)       Date:  2016-12-16       Impact factor: 3.775

Review 9.  The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies.

Authors:  Berish Y Rubin; Sylvia L Anderson
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

10.  A review of treatment of Pompe disease in infants.

Authors:  Yin-Hsiu Chien; Wuh-Liang Hwu
Journal:  Biologics       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.